Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

davita inc. - DVA

DVA

Close Chg Chg %
141.58 -1.58 -1.12%

Closed Market

140.00

-1.58 (1.12%)

Volume: 994.97K

Last Updated:

Apr 17, 2025, 3:59 PM EDT

Trade Now

Company Overview: davita inc. - DVA

DVA Key Data

Open

$140.87

 Day Range

136.54 - 141.59

52 Week Range

125.68 - 179.60

 Market Cap

$11.20B

Shares Outstanding

80.00M

 Public Float

76.13M

Beta

1.04

 Rev. Per Employee

N/A

P/E Ratio

13.05

 EPS

$11.03

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

853.49K

  

DVA Performance

1 Week
 
 -9.95%
 
1 Month
 
 -5.48%
 
3 Months
 
 -15.77%
 
1 Year
 
 9.55%
 
5 Years
 
 79.16%
 

DVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About davita inc. - DVA

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DVA At a Glance

DaVita, Inc.
2000 16th Street
Denver, Colorado 80202-7198
Phone 1-720-631-2100 Revenue 12.82B
Industry Medical/Nursing Services Net Income 936.34M
Sector Health Services 2024 Sales Growth 5.563%
Fiscal Year-end 12 / 2025 Employees 76,000
View SEC Filings

DVA Valuation

P/E Current 13.189
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 13.939
Price to Sales Ratio 1.018
Price to Book Ratio 99.438
Price to Cash Flow Ratio 6.434
Enterprise Value to EBITDA 9.765
Enterprise Value to Sales 2.041
Total Debt to Enterprise Value 0.461

DVA Efficiency

Revenue/Employee 168,625.658
Income Per Employee 12,320.289
Receivables Turnover 5.011
Total Asset Turnover 0.72

DVA Liquidity

Current Ratio 1.26
Quick Ratio 1.215
Cash Ratio 0.313

DVA Profitability

Gross Margin 27.257
Operating Margin 15.254
Pretax Margin 11.942
Net Margin 7.306
Return on Assets 5.262
Return on Equity 159.077
Return on Total Capital 7.683
Return on Invested Capital 8.085

DVA Capital Structure

Total Debt to Total Equity 9,962.547
Total Debt to Total Capital 99.006
Total Debt to Total Assets 67.143
Long-Term Debt to Equity 9,400.074
Long-Term Debt to Total Capital 93.416
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Davita Inc. - DVA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
11.62B 11.61B 12.14B 12.82B
Sales Growth
+0.59% -0.08% +4.57% +5.56%
Cost of Goods Sold (COGS) incl D&A
8.65B 8.94B 9.07B 9.32B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
680.62M 732.60M 745.44M 723.86M
Depreciation
667.75M 721.13M 736.47M 716.40M
Amortization of Intangibles
12.86M 11.47M 8.97M 7.46M
COGS Growth
+0.39% +3.34% +1.38% +2.84%
Gross Income
2.97B 2.67B 3.07B 3.49B
Gross Income Growth
+1.17% -10.05% +15.27% +13.60%
Gross Profit Margin
+25.53% +22.98% +25.33% +27.26%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.20B 1.36B 1.47B 1.54B
Research & Development
- - - -
-
Other SG&A
1.20B 1.36B 1.47B 1.54B
SGA Growth
-4.19% +13.37% +8.77% +4.37%
Other Operating Expense
- - - -
-
Unusual Expense
2.48M (5.92M) 22.88M (89.65M)
EBIT after Unusual Expense
1.77B 1.32B 1.58B 2.04B
Non Operating Income/Expense
30.28M (6.90M) (106.05M) (101.79M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
26.94M 26.52M 27.86M 26.19M
Interest Expense
279.75M 345.29M 294.98M 412.29M
Interest Expense Growth
-5.82% +23.43% -14.57% +39.77%
Gross Interest Expense
295.02M 357.96M 304.16M 420.27M
Interest Capitalized
15.28M 12.68M 9.18M 7.98M
Pretax Income
1.52B 966.28M 1.18B 1.53B
Pretax Income Growth
+15.19% -36.37% +21.82% +30.01%
Pretax Margin
+13.07% +8.32% +9.70% +11.94%
Income Tax
306.73M 198.09M 220.12M 279.66M
Income Tax - Current - Domestic
232.14M 257.52M 238.44M 305.91M
Income Tax - Current - Foreign
14.25M 16.25M 21.01M 31.53M
Income Tax - Deferred - Domestic
64.87M (78.69M) (39.87M) (50.57M)
Income Tax - Deferred - Foreign
(4.53M) 3.00M 535.00K (7.22M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
26.94M 26.52M 27.86M 26.19M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.21B 768.19M 956.98M 1.25B
Minority Interest Expense
233.31M 221.24M 265.44M 314.39M
Net Income
978.45M 546.95M 691.53M 936.34M
Net Income Growth
+24.91% -44.10% +26.44% +35.40%
Net Margin Growth
+8.42% +4.71% +5.70% +7.31%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
978.45M 546.95M 691.53M 936.34M
Preferred Dividends
- - - -
-
Net Income Available to Common
978.45M 546.95M 691.53M 936.34M
EPS (Basic)
9.2982 5.8817 7.6169 11.017
EPS (Basic) Growth
+42.21% -36.74% +29.50% +44.64%
Basic Shares Outstanding
105.23M 92.99M 90.79M 84.99M
EPS (Diluted)
8.8992 5.7072 7.4213 10.7288
EPS (Diluted) Growth
+39.32% -35.87% +30.03% +44.57%
Diluted Shares Outstanding
109.95M 95.83M 93.18M 87.27M
EBITDA
2.45B 2.05B 2.35B 2.68B
EBITDA Growth
+5.90% -16.56% +14.73% +14.16%
EBITDA Margin
+21.10% +17.62% +19.33% +20.90%

Snapshot

Average Recommendation HOLD Average Target Price 169.143
Number of Ratings 12 Current Quarters Estimate 2.902
FY Report Date 06 / 2025 Current Year's Estimate 11.026
Last Quarter’s Earnings 1.93 Median PE on CY Estimate N/A
Year Ago Earnings 9.68 Next Fiscal Year Estimate 13.024
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 8 7
Mean Estimate 2.90 3.25 11.03 13.02
High Estimates 3.03 3.30 11.82 13.71
Low Estimate 2.85 3.20 10.69 12.40
Coefficient of Variance 2.50 1.29 3.44 4.05

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 10 10 8
UNDERWEIGHT 1 1 2
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Davita Inc. - DVA

Date Name Shares Transaction Value
Mar 21, 2025 Charles G. Berg Director 19,634 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Javier J. Rodriguez Chief Executive Officer; Director 52,106 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 105,092 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 102,333 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,679,668.85
Mar 21, 2025 Dennis W. Pullin Director 961 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Pamela M. Arway Director 25,235 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Christopher M. Berry Chief Accounting Officer 15,991 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 9,263 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 David P. Maughan Chief Operating Officer, DKC 14,474 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 98,693 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,157,510.85
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 97,754 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,022,811.30
Mar 21, 2025 Barbara Jean Desoer Director 349 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Joel Ackerman CFO and Treasuer 16,597 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Joel Ackerman CFO and Treasuer 141,640 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 20,318,258.00
Mar 21, 2025 Joel Ackerman CFO and Treasuer 144,971 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 20,796,089.95
Mar 21, 2025 Joel Ackerman CFO and Treasuer 148,064 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 99,648 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,294,505.60
Mar 21, 2025 Javier J. Rodriguez Chief Executive Officer; Director 894,080 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Adam H. Schechter Director 3,982 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Wendy Lee Schoppert Director 349 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Davita Inc. in the News